Skip to content
TrialScanner

NCT01661192

Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 Diabetes

Phase 2CompletedKMDACollaborator

Registry record

Lead sponsor
Rabin Medical Center
Conditions
Type 1 Diabetes; Beta Cell Preservation
Primary completion
Jan 2017Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01661192 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01661192: Long Term Treatment Effect... | TrialScanner